Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity
- PMID: 27581664
- PMCID: PMC5007834
- DOI: 10.1186/s13049-016-0299-z
Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity
Abstract
Background: γ-Hydroxybutyrate (GHB) is a drug of abuse with dose-dependent sedative effects. Systematic data on the acute toxicity of GHB from emergency department (ED) presentations over a long period of time are currently missing from the literature. The present study described the clinical features of GHB toxicity.
Methods: Retrospective case series of GHB intoxications seen in an urban ED.
Results: From January 2002 to September 2015, 78 GHB-related intoxication cases were recorded (71 % male patients). The mean ± SD age was 29 ± 8 years. The co-use of alcohol and/or other illicit drugs was reported in 65 % of the cases. Neurological symptoms other than central nervous system depression included agitation (40 %) and clonus (21 %). The most frequent reasons for admission were coma (64 %) and agitation (23 %). The median time to regain consciousness was 90 min (range, 3-400 min). Sudden recovery was reported in 25 cases (32 %). Coma was not significantly associated with polyintoxication. Coma occurred in 77 % of the alcohol co-users and in 62 % ofthe non-alcohol users (p=0.052). The mean recovery time in comatose patients was 142 min in patients with co-use of alcohol compared with 89 min in patients without alcohol co-use (p=0.07). Alcohol co-use was not significantly associated with nausea/vomiting (p=0.07). The co-use of stimulants was not significantly associated with non-responsive coma (Glasgow Coma Scale = 3) or mean recovery time. Analytical confirmation of GHB was available in 37 cases (47 %), with additional quantitative analysis in 20 cases. The median GHB concentration was 240 mg/L (range, 8.3-373 mg/L). Intoxication was severe in 72 % of the cases. No fatalities occurred, and 72 % of the patients were discharged directly home from the ED.
Discussion: There were trend associations between alcohol co-use and frequency and length of coma and nausea/vomiting which did not reach the significance level (all p=0.05-0.07) but may nevertheless be clinically relevant. As the exact time of use is not always known, and co-use of other substances can affect the severity of poisoning, no definitive conclusions can be drawn regarding the association between GHB concentration and severity.
Conclusion: Impaired consciousness and agitation were typical findings of GHB intoxication. The co-use of alcohol and/or other illicit substances is common but was not significantly associated with the severity of the intoxications in our study.
Keywords: Acute toxicity; GHB; Gamma-hydroxybutyrate.
Figures
Similar articles
-
Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.Toxicol Lett. 2017 Aug 5;277:84-91. doi: 10.1016/j.toxlet.2017.05.030. Epub 2017 Jun 1. Toxicol Lett. 2017. PMID: 28579487
-
Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.Drug Alcohol Depend. 2006 Feb 28;81(3):323-6. doi: 10.1016/j.drugalcdep.2005.07.010. Epub 2005 Sep 6. Drug Alcohol Depend. 2006. PMID: 16143455
-
A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.Drug Alcohol Rev. 2024 May;43(4):984-996. doi: 10.1111/dar.13830. Epub 2024 Mar 1. Drug Alcohol Rev. 2024. PMID: 38426636
-
The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.Clin Toxicol (Phila). 2012 Jul;50(6):458-70. doi: 10.3109/15563650.2012.702218. Clin Toxicol (Phila). 2012. PMID: 22746383 Review.
-
Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.Am J Emerg Med. 2011 Mar;29(3):319-32. doi: 10.1016/j.ajem.2009.11.008. Epub 2010 Apr 28. Am J Emerg Med. 2011. PMID: 20825811 Review.
Cited by
-
Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks.Hum Brain Mapp. 2019 Jun 1;40(8):2413-2421. doi: 10.1002/hbm.24532. Epub 2019 Feb 5. Hum Brain Mapp. 2019. PMID: 30720906 Free PMC article.
-
Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity.Front Psychiatry. 2020 Apr 2;11:166. doi: 10.3389/fpsyt.2020.00166. eCollection 2020. Front Psychiatry. 2020. PMID: 32300311 Free PMC article.
-
γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.AAPS J. 2021 Jan 8;23(1):22. doi: 10.1208/s12248-020-00543-z. AAPS J. 2021. PMID: 33417072 Free PMC article. Review.
-
Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.Clin Pharmacol Ther. 2019 May;105(5):1196-1203. doi: 10.1002/cpt.1306. Epub 2019 Jan 8. Clin Pharmacol Ther. 2019. PMID: 30450642 Free PMC article. Clinical Trial.
-
Designer drugs: mechanism of action and adverse effects.Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6. Arch Toxicol. 2020. PMID: 32249347 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials